108966 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing N- glycosyl compounds (3.2.2)
TRANSCRIPTIONAL REGULATORS AND POLYNUCLEOTIDES ENCODING THE SAME
#2METHODS AND PRODUCTS FOR REMOVAL OF URACIL CONTAINING POLYNUCLEOTIDES
#3METHOD FOR PRODUCING METHYL COMPOUND
#4Lipid Nanoparticles Comprising Nucleic Acids Encoding Therapeutic Genes and Uses in Medical Methods
#5SINGLE BASE SUBSTITUTION PROTEIN, AND COMPOSITION COMPRISING SAME
#6Protected DNA and Methods for the Production Thereof
#7COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES
#8METHODS AND CELLS FOR THE PRODUCTION OF FLUORINATED COMPOUNDS
#9SUBSTRATE CLEAVAGE FOR NUCLEIC ACID SYNTHESIS
#10MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE
#11PROGRAMMABLE ADENINE BASE EDITOR AND USES THEREOF
#12SINGLE-STRANDED END PRESERVING ADAPTORS
#13NUCLEOBASE EDITORS AND USES THEREOF
#14NUCLEOBASE EDITORS COMPRISING GEOCAS9 AND USES THEREOF
#15Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof
#16PLANT LECTINS AS CARRIERS OF ASSOCIATED DRUG SUBSTANCES INTO ANIMAL AND HUMAN CELLS
#17FUSION PROTEINS AND USES THEREOF
#18INHIBITION OF DNA POLYMERASES BY URACIL-DNA GLYCOSYLASE-CLEAVABLE OLIGONUCLEOTIDE LIGANDS
#19PRODUCTION OF PSYCHEDELIC COMPOUNDS
#20EVOLVED CAS9 PROTEINS FOR GENE EDITING
#21MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#22DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#23HETEROLOGOUS PRODUCTION OF CYTOKININS IN YEASTS
#24RICE GRAIN WITH THICKENED ALEURONE
#25IN VIVO FLUORINATION
#26METHODS FOR PERFORMING IN VITRO TRANSCRIPTION USING dUTP
#27Methods of Library Preparation
#28ANTI-KIT ANTIBODIES AND USES THEREOF
#29TARGETED DNA DEMETHYLATION AND METHYLATION
#30METHOD FOR MODIFYING DNA BY UTILIZING GLYCOSYLASE AND OXYAMINE COMPOUND
#31PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES
#32CYTOSINE TO GUANINE BASE EDITOR
#33GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS
#34ADENINE BASE EDITOR HAVING INCREASED THYMINE-CYTOSINE SEQUENCE-SPECIFIC CYTOSINE EDITING ACTIVITY, AND USE THEREOF
#35ENZYMATIC OLIGONUCLEOTIDE ASSEMBLY USING HAIRPINS AND ENZYMATIC CLEAVAGE
#36METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS
#37CLEAVABLE DNA-ENCODED LIBRARY
#38RECOMBINANT VECTOR OF THERMOLABILE UNG FUSED PROTEIN AND AN EXPRESSING AND PURIFYING METHOD
#39Plant lectins as carriers of associated drug substances into animal and human cells
#40Site-specific antibody-drug conjugates by ADP-ribosyl cyclases
#41METHODS OF NUCLEIC ACID SYNTHESIS
#42METHODS AND COMPOSITIONS RELATED TO A HYBRID DNA REPAIR GLYCOSYLASE AND A THERMOSTABLE DNA LYASE
#43Rice grain with reduced ROS1a activity
#44Nucleobase editors comprising GeoCas9 and uses thereof
#45BASE EDITING SYSTEMS FOR ACHIEVING C TO A AND C TO G BASE MUTATION AND APPLICATION THEREOF
#46METHOD OF OLIGONUCLEOTIDE SYNTHESIS
#47MHC class I epitope delivering polypeptides
#48Cleavage of Single Stranded DNA Having a Modified Nucleotide
#49De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#50IMPROVED GENE EDITING SYSTEM
#51Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
#52NOVEL ADP-RIBOSYL CYCLASE AND INHIBITOR THEREOF
#53SINGLE BASE SUBSTITUTION PROTEIN, AND COMPOSITION COMPRISING SAME
#54NUCLEOBASE EDITORS AND USES THEREOF
#55A GENETICALLY ENCODED PROTEIN SYNTHESIS INHIBITOR
#56TARGETED DELIVERY OF THE ABRIN-A A-CHAIN TO CANCER CELLS
#57COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING
#58NUCLEOBASE EDITORS HAVING REDUCED OFF-TARGET DEAMINATION AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE TARGET SEQUENCE
#59CELL FACTORIES FOR IMPROVED PRODUCTION OF COMPOUNDS AND PROTEINS DEPENDENT ON IRON SULFUR CLUSTERS
#60PROGRAMMABLE NUCLEASES AND BASE EDITORS FOR MODIFYING NUCLEIC ACID DUPLEXES
#61Enzymes for trimming of glycoproteins
#62Enzymes and methods for cleaving n-glycans from glycoproteins
#63MHC class I epitope delivering polypeptides
#64Cytosine to guanine base editor
#65METHOD FOR MODIFYING GENOME SEQUENCE TO INTRODUCE SPECIFIC MUTATION TO TARGETED DNA SEQUENCE BY BASE-REMOVAL REACTION, AND MOLECULAR COMPLEX USED THEREIN
#66NOVEL SYSTEMS FOR SCREENING INTERNALIZING ANTIBODY AND USES THEREOF
#67Nucleosidase agent having reduced contaminant activity
#68Complex for genome editing having stability and few side-effects, and nucleic acid coding same
#69CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
#70Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
#71Anti-KIT antibodies and uses thereof
#72Enzymes and methods for cleaving n-glycans from glycoproteins
#73Methods and kits for quantifying adenosine-containing molecules
#74Gene transfer systems for stem cell engineering
#75MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS
#76POLYPEPTIDES
#77Targeted DNA demethylation and methylation
#78Enzymes and methods for cleaving N-glycans from glycoproteins
#79Enzymes and methods for cleaving N-glycans from glycoproteins
#80Antibody-drug conjugates and the use of same in therapy
#81Evolved Cas9 proteins for gene editing
#82Method for producing nucleic acid seasoning
#83TARGETED ENHANCED DNA DEMETHYLATION
#84Nucleosidase
#85MHC Class I Epitope Delivering Polypeptides
#86Antibody-drug conjugates and immunotoxins
#87Methods of treating by administering anti-kit antibodies
#88Enzymes and methods for cleaving N-glycans from glycoproteins
#89Enzymes for trimming of glycoproteins
#90Rice grain with reduced ROS1A activity
#91Nucleobase editors and uses thereof
#92CELL-TARGETING MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#93ANTI-CD38 HUMAN ANTIBODIES AND USES THEREFOR
#94AN IMMUNOTOXIN FOR USE IN THE TREATMENT OF LEISHMANIASIS
#95OXIDIZED PROTEIN HYDROLASE ACTIVITY ENHANCING AGENT AND GLYCATION STRESS INHIBITOR
#96Method for modifying genome sequence to introduce specific mutation to targeted DNA sequence by base-removal reaction, and molecular complex used therein
#97Plant lectins as carriers of associated drug substances into animal and human cells
#98LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS
#99IMPROVED NGS WORKFLOW
#100Nucleobase editors and uses thereof
#101Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
#102Polynucleotides encoding anti-KIT antibodies
#103Antibody-drug conjugates and immunotoxins
#104Antibody-drug conjugates and immunotoxins
#105Microorganisms having enhanced L-amino acids productivity and process for producing L-amino acids using the same
#106DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#107Enzymes and methods for cleaving N-glycans from glycoproteins
#108Vaccines comprising polypeptides for the treatment and diagnosis of leishmaniasis
#109CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#110Antibody-drug conjugates and the use of same in therapy
#111Antigen binding protein and its use as addressing product for the treatment of cancer
#112Anti-CD38 human antibodies and uses thereof
#113Plant lectins as carriers of associated drug substances into animal and human cells
#114ANTIMICROBIAL FUSION COMPOUNDS AND USES THEREOF
#115TARGETED ELIMINATION OF FACTOR VIII IMMUNE CELLS
#116Method for delivering agents into cells using bacterial toxins
#117Phosphodeoxyribosyl transferase mutant enzymes and uses thereof
#118Treatment of disease conditions via administration of DNA repair enzyme
#119Enzymes and methods for cleaving N-glycans from glycoproteins
#120Antigen binding protein and its use as addressing product for the treatment of cancer
#121Vectors harboring toxic genes, methods and uses therefor
#122Anti-kit antibodies
#123MAGI POLYNUCLEOTIDES, POLYPETIDES, AND ANTIBODIES
#124ANTI-KIT ANTIBODIES AND USES THEREOF
#125ANTI-CD38 HUMAN ANTIBODIES AND USES THEREOF
#126Engineered demeter 5-methylcytosine DNA glyosylase with improved yield, stability and solubility
#127VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS
#128Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i
#129Microorganism producing inosine and method of producing inosine using the same
#130Anti-CD38 human antibodies and uses thereof
#131Treatment of disease conditions via administration of DNA repair enzyme
#132MODIFIED ENZYMES AND THEIR USES
#133Inosine producing microorganism belonging to the genus and process of producing inosine using the same
#134DNA REPAIR POLYPEPTIDES AND METHODS OF DELIVERY AND USE
#135CD38 modulated chemotaxis
#136Anti-CD38 human antibodies and uses thereof
#137Production Of CPD Glycosylases
#138Microorganism producing inosine and method of producing inosine using the same
#139MAGI POLYNUCLEOTIDES, POLYPEPTIDES, AND ANTIBODIES
#140Screening methods and sequences relating thereto
#141Uracil-DNA glycosylase of sp. HJ147 and use thereof
#142Production of CPD glycosylases
#143MAGI polynucleotides, polypeptides, and antibodies
#144Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#145Mutant forms of meningococcal ADP-ribosylating toxin
#146Screening methods and sequences relating thereto
#147DNA glycosylases and their use
#148SM38 nucleic acid molecules